Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Angioplasty, Balloon, Coronary | 47 | 2012 | 1724 | 1.670 |
Why?
|
Stents | 44 | 2019 | 3204 | 1.080 |
Why?
|
Coronary Restenosis | 15 | 2011 | 396 | 0.920 |
Why?
|
Radial Artery | 4 | 2021 | 188 | 0.920 |
Why?
|
Catheterization, Peripheral | 3 | 2021 | 346 | 0.720 |
Why?
|
Pericarditis | 1 | 2021 | 136 | 0.690 |
Why?
|
Coronary Stenosis | 10 | 2019 | 803 | 0.680 |
Why?
|
Heart Injuries | 1 | 2021 | 207 | 0.670 |
Why?
|
Hospital Mortality | 13 | 2014 | 5371 | 0.600 |
Why?
|
Coronary Angiography | 40 | 2021 | 4526 | 0.520 |
Why?
|
Wrist | 1 | 2017 | 232 | 0.520 |
Why?
|
Coronary Disease | 29 | 2011 | 5926 | 0.510 |
Why?
|
Registries | 24 | 2021 | 8373 | 0.480 |
Why?
|
Myocarditis | 1 | 2021 | 804 | 0.450 |
Why?
|
Coronary Thrombosis | 10 | 2012 | 440 | 0.440 |
Why?
|
Angiography | 1 | 2017 | 1598 | 0.400 |
Why?
|
Myocardium | 6 | 2021 | 4788 | 0.370 |
Why?
|
Atherectomy, Coronary | 9 | 2006 | 138 | 0.350 |
Why?
|
Myocardial Infarction | 23 | 2019 | 11515 | 0.340 |
Why?
|
Vaccination | 1 | 2021 | 3434 | 0.320 |
Why?
|
Risk Adjustment | 3 | 2010 | 603 | 0.300 |
Why?
|
Electrocardiography | 11 | 2019 | 6410 | 0.300 |
Why?
|
Coronary Circulation | 1 | 2012 | 1617 | 0.270 |
Why?
|
Myocardial Ischemia | 7 | 2019 | 2139 | 0.230 |
Why?
|
Endovascular Procedures | 1 | 2017 | 2258 | 0.220 |
Why?
|
Aged | 85 | 2022 | 171520 | 0.220 |
Why?
|
Troponin I | 2 | 2009 | 662 | 0.220 |
Why?
|
Acute Coronary Syndrome | 2 | 2013 | 2195 | 0.210 |
Why?
|
Carotid Artery Diseases | 3 | 2019 | 879 | 0.210 |
Why?
|
Drug-Eluting Stents | 4 | 2014 | 681 | 0.190 |
Why?
|
Patient Identification Systems | 1 | 2001 | 75 | 0.190 |
Why?
|
Blood Chemical Analysis | 1 | 2003 | 436 | 0.190 |
Why?
|
Middle Aged | 86 | 2021 | 223418 | 0.180 |
Why?
|
Coronary Artery Disease | 8 | 2018 | 6551 | 0.180 |
Why?
|
Punctures | 3 | 2018 | 372 | 0.180 |
Why?
|
Treatment Outcome | 56 | 2022 | 65409 | 0.180 |
Why?
|
Thrombectomy | 5 | 2003 | 706 | 0.180 |
Why?
|
Graft Occlusion, Vascular | 6 | 2003 | 538 | 0.170 |
Why?
|
Cardiology | 5 | 2019 | 1701 | 0.170 |
Why?
|
Follow-Up Studies | 34 | 2021 | 39430 | 0.170 |
Why?
|
Sirolimus | 4 | 2008 | 1542 | 0.160 |
Why?
|
Male | 97 | 2022 | 364781 | 0.160 |
Why?
|
Creatine Kinase, MB Form | 4 | 2016 | 202 | 0.160 |
Why?
|
Models, Cardiovascular | 2 | 2011 | 986 | 0.160 |
Why?
|
Logistic Models | 15 | 2014 | 13324 | 0.160 |
Why?
|
Risk Assessment | 16 | 2016 | 24311 | 0.160 |
Why?
|
Endarterectomy, Carotid | 4 | 2019 | 558 | 0.160 |
Why?
|
Survival Analysis | 16 | 2013 | 10125 | 0.150 |
Why?
|
Female | 95 | 2022 | 396943 | 0.150 |
Why?
|
Massachusetts | 10 | 2016 | 8908 | 0.150 |
Why?
|
Troponin | 1 | 2021 | 534 | 0.150 |
Why?
|
Incidence | 16 | 2021 | 21552 | 0.150 |
Why?
|
Decision Support Techniques | 4 | 2015 | 2010 | 0.150 |
Why?
|
Platelet Glycoprotein GPIIb-IIIa Complex | 3 | 2008 | 578 | 0.150 |
Why?
|
Time Factors | 27 | 2021 | 40271 | 0.150 |
Why?
|
Myocardial Reperfusion | 2 | 2008 | 339 | 0.140 |
Why?
|
Snow | 1 | 2017 | 15 | 0.140 |
Why?
|
Coronary Artery Bypass | 7 | 2006 | 2194 | 0.140 |
Why?
|
Peripheral Arterial Disease | 2 | 2019 | 1299 | 0.140 |
Why?
|
Blood Vessel Prosthesis Implantation | 9 | 2007 | 1460 | 0.140 |
Why?
|
Neuregulin-1 | 2 | 2009 | 136 | 0.140 |
Why?
|
Pulmonary Wedge Pressure | 1 | 2018 | 278 | 0.140 |
Why?
|
Humans | 123 | 2022 | 768451 | 0.130 |
Why?
|
Sex Factors | 5 | 2021 | 10647 | 0.130 |
Why?
|
Feasibility Studies | 7 | 2018 | 5308 | 0.130 |
Why?
|
Discriminant Analysis | 2 | 2013 | 224 | 0.130 |
Why?
|
Postoperative Complications | 12 | 2016 | 15880 | 0.130 |
Why?
|
Quality Improvement | 5 | 2022 | 3858 | 0.130 |
Why?
|
Risk Factors | 27 | 2018 | 74915 | 0.130 |
Why?
|
Referral and Consultation | 3 | 2018 | 3629 | 0.120 |
Why?
|
Quality Indicators, Health Care | 4 | 2014 | 1813 | 0.120 |
Why?
|
Angioplasty, Balloon | 4 | 2011 | 592 | 0.120 |
Why?
|
Vascular System Injuries | 1 | 2018 | 251 | 0.120 |
Why?
|
Vasoconstriction | 1 | 2017 | 594 | 0.120 |
Why?
|
Nonlinear Dynamics | 1 | 1997 | 496 | 0.120 |
Why?
|
Myocardial Revascularization | 5 | 2008 | 796 | 0.120 |
Why?
|
Angina Pectoris | 1 | 2018 | 960 | 0.120 |
Why?
|
Heart Failure | 7 | 2004 | 11857 | 0.120 |
Why?
|
Specialization | 1 | 2019 | 782 | 0.110 |
Why?
|
Exercise Tolerance | 1 | 2019 | 849 | 0.110 |
Why?
|
Early Diagnosis | 1 | 2019 | 1196 | 0.110 |
Why?
|
Saphenous Vein | 4 | 2004 | 519 | 0.110 |
Why?
|
Patient Selection | 6 | 2015 | 4266 | 0.110 |
Why?
|
Myocardial Perfusion Imaging | 1 | 2019 | 672 | 0.110 |
Why?
|
Platelet Aggregation Inhibitors | 6 | 2022 | 2768 | 0.110 |
Why?
|
Disclosure | 1 | 2019 | 750 | 0.110 |
Why?
|
Workload | 1 | 2019 | 852 | 0.110 |
Why?
|
Hospitals | 4 | 2022 | 3906 | 0.100 |
Why?
|
Treatment Failure | 2 | 2017 | 2656 | 0.100 |
Why?
|
Antacids | 1 | 2013 | 94 | 0.100 |
Why?
|
Multivariate Analysis | 8 | 2014 | 12096 | 0.100 |
Why?
|
Unnecessary Procedures | 1 | 2015 | 420 | 0.100 |
Why?
|
Vascular Malformations | 1 | 2017 | 469 | 0.100 |
Why?
|
United States | 27 | 2019 | 73121 | 0.100 |
Why?
|
Atrial Fibrillation | 4 | 2022 | 5162 | 0.100 |
Why?
|
Heart Atria | 1 | 2018 | 1361 | 0.100 |
Why?
|
Databases, Factual | 2 | 2011 | 8081 | 0.100 |
Why?
|
Electrocardiography, Ambulatory | 3 | 2000 | 578 | 0.090 |
Why?
|
Exercise Test | 1 | 2019 | 2186 | 0.090 |
Why?
|
Mortality | 2 | 2002 | 2917 | 0.090 |
Why?
|
Sweating, Gustatory | 1 | 1990 | 7 | 0.090 |
Why?
|
Odds Ratio | 7 | 2013 | 9687 | 0.090 |
Why?
|
Hospitalization | 6 | 2019 | 10845 | 0.090 |
Why?
|
Interviews as Topic | 1 | 2018 | 2733 | 0.090 |
Why?
|
Embolism | 3 | 2004 | 401 | 0.090 |
Why?
|
Creatine Kinase | 4 | 2009 | 685 | 0.090 |
Why?
|
Ganglia, Sympathetic | 1 | 1990 | 65 | 0.090 |
Why?
|
Ticlopidine | 3 | 2008 | 730 | 0.090 |
Why?
|
Urokinase-Type Plasminogen Activator | 2 | 2002 | 325 | 0.090 |
Why?
|
Aged, 80 and over | 16 | 2018 | 59680 | 0.090 |
Why?
|
Vascular Surgical Procedures | 1 | 2019 | 1509 | 0.090 |
Why?
|
Heart Rate | 2 | 2003 | 4218 | 0.090 |
Why?
|
Quality Assurance, Health Care | 3 | 2011 | 2179 | 0.090 |
Why?
|
Survival Rate | 10 | 2019 | 12875 | 0.090 |
Why?
|
Equipment Design | 8 | 2014 | 3530 | 0.090 |
Why?
|
Societies, Medical | 3 | 2011 | 3955 | 0.090 |
Why?
|
Product Surveillance, Postmarketing | 1 | 2014 | 463 | 0.090 |
Why?
|
Hemorrhage | 3 | 2017 | 3458 | 0.090 |
Why?
|
Troponin T | 2 | 2016 | 787 | 0.080 |
Why?
|
Quality of Life | 6 | 2021 | 13497 | 0.080 |
Why?
|
Pulmonary Artery | 1 | 2018 | 1949 | 0.080 |
Why?
|
Health Status | 2 | 2021 | 4096 | 0.080 |
Why?
|
Shock, Cardiogenic | 2 | 2013 | 711 | 0.080 |
Why?
|
Equipment Safety | 2 | 2014 | 250 | 0.080 |
Why?
|
Predictive Value of Tests | 7 | 2015 | 15460 | 0.080 |
Why?
|
American Heart Association | 3 | 2008 | 1049 | 0.080 |
Why?
|
Bundle-Branch Block | 1 | 2010 | 278 | 0.080 |
Why?
|
Fibrinolytic Agents | 3 | 2022 | 2082 | 0.070 |
Why?
|
Receptor, Angiotensin, Type 2 | 1 | 2008 | 61 | 0.070 |
Why?
|
Hemorheology | 3 | 2003 | 144 | 0.070 |
Why?
|
Cardiovascular Diseases | 4 | 2019 | 15638 | 0.070 |
Why?
|
Hypertension | 4 | 2008 | 8611 | 0.070 |
Why?
|
Angioplasty | 1 | 2010 | 357 | 0.070 |
Why?
|
Cohort Studies | 10 | 2021 | 41797 | 0.070 |
Why?
|
Vectorcardiography | 2 | 2010 | 48 | 0.070 |
Why?
|
Multicenter Studies as Topic | 4 | 2006 | 1727 | 0.070 |
Why?
|
Health Policy | 1 | 2019 | 2699 | 0.070 |
Why?
|
Age Factors | 8 | 2011 | 18478 | 0.060 |
Why?
|
Boston | 8 | 2018 | 9361 | 0.060 |
Why?
|
Retrospective Studies | 19 | 2021 | 81834 | 0.060 |
Why?
|
Adult | 18 | 2021 | 223542 | 0.060 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2013 | 1126 | 0.060 |
Why?
|
Young Adult | 4 | 2021 | 60045 | 0.060 |
Why?
|
Reoperation | 3 | 2005 | 4342 | 0.060 |
Why?
|
Leg | 2 | 2019 | 1089 | 0.060 |
Why?
|
Prospective Studies | 15 | 2019 | 54914 | 0.060 |
Why?
|
Cardiomegaly | 1 | 2008 | 591 | 0.060 |
Why?
|
Adolescent | 7 | 2021 | 89168 | 0.060 |
Why?
|
Prognosis | 9 | 2021 | 30028 | 0.060 |
Why?
|
Cardiac Output, Low | 1 | 2005 | 191 | 0.060 |
Why?
|
Immunosuppressive Agents | 2 | 2007 | 4213 | 0.060 |
Why?
|
Proportional Hazards Models | 5 | 2004 | 12561 | 0.060 |
Why?
|
Thrombosis | 3 | 2004 | 2956 | 0.060 |
Why?
|
Autoanalysis | 1 | 2003 | 70 | 0.050 |
Why?
|
Hospital Costs | 4 | 2003 | 959 | 0.050 |
Why?
|
Coronary Vessels | 3 | 2005 | 3122 | 0.050 |
Why?
|
Death | 1 | 2008 | 683 | 0.050 |
Why?
|
Cardiovascular Agents | 1 | 2009 | 849 | 0.050 |
Why?
|
Technetium | 1 | 2003 | 326 | 0.050 |
Why?
|
Sampling Studies | 1 | 2004 | 617 | 0.050 |
Why?
|
Strontium Radioisotopes | 1 | 2002 | 18 | 0.050 |
Why?
|
Ventricular Dysfunction, Left | 2 | 2009 | 2145 | 0.050 |
Why?
|
Medical Audit | 2 | 2015 | 454 | 0.050 |
Why?
|
Drug Delivery Systems | 4 | 2007 | 2238 | 0.050 |
Why?
|
Beta Particles | 1 | 2002 | 51 | 0.050 |
Why?
|
Isoenzymes | 2 | 2004 | 1685 | 0.050 |
Why?
|
Carotid Stenosis | 1 | 2010 | 864 | 0.050 |
Why?
|
Doxorubicin | 2 | 2009 | 2229 | 0.050 |
Why?
|
Heart Diseases | 2 | 2009 | 2816 | 0.050 |
Why?
|
Stroke | 4 | 2019 | 9791 | 0.050 |
Why?
|
Radiography | 2 | 2011 | 6995 | 0.050 |
Why?
|
Autoantibodies | 1 | 1990 | 2131 | 0.050 |
Why?
|
Drug Utilization Review | 1 | 2003 | 248 | 0.050 |
Why?
|
Ulnar Artery | 1 | 2021 | 15 | 0.050 |
Why?
|
Yttrium Radioisotopes | 1 | 2002 | 114 | 0.050 |
Why?
|
Social Security | 1 | 2001 | 101 | 0.050 |
Why?
|
Arrhythmias, Cardiac | 3 | 2005 | 2258 | 0.050 |
Why?
|
Ultrasonic Therapy | 1 | 2003 | 217 | 0.050 |
Why?
|
Health Services Accessibility | 1 | 2019 | 5510 | 0.050 |
Why?
|
Catheters, Indwelling | 2 | 2002 | 436 | 0.050 |
Why?
|
Smoking | 3 | 2004 | 9099 | 0.050 |
Why?
|
Hypertrophy, Left Ventricular | 2 | 1997 | 857 | 0.050 |
Why?
|
Tachycardia | 1 | 2003 | 599 | 0.050 |
Why?
|
False Positive Reactions | 1 | 2003 | 962 | 0.040 |
Why?
|
Algorithms | 5 | 2003 | 14158 | 0.040 |
Why?
|
Practice Guidelines as Topic | 3 | 2010 | 7451 | 0.040 |
Why?
|
Data Collection | 3 | 2019 | 3329 | 0.040 |
Why?
|
Pericardial Effusion | 1 | 2002 | 246 | 0.040 |
Why?
|
Randomized Controlled Trials as Topic | 6 | 2008 | 10358 | 0.040 |
Why?
|
Hemostasis, Surgical | 1 | 2000 | 127 | 0.040 |
Why?
|
Quality of Health Care | 2 | 2019 | 4340 | 0.040 |
Why?
|
Hyperlipidemias | 1 | 2004 | 773 | 0.040 |
Why?
|
Kidney Failure, Chronic | 2 | 2003 | 2489 | 0.040 |
Why?
|
Diabetes Complications | 1 | 2006 | 1322 | 0.040 |
Why?
|
Paclitaxel | 1 | 2007 | 1737 | 0.040 |
Why?
|
Echocardiography, Doppler | 1 | 2003 | 899 | 0.040 |
Why?
|
Brachytherapy | 2 | 2007 | 1227 | 0.040 |
Why?
|
Ventricular Function, Right | 1 | 2003 | 629 | 0.040 |
Why?
|
Chi-Square Distribution | 2 | 2019 | 3438 | 0.040 |
Why?
|
Needles | 1 | 2002 | 455 | 0.040 |
Why?
|
Myocytes, Cardiac | 1 | 2008 | 1683 | 0.040 |
Why?
|
Drug Therapy, Combination | 3 | 2022 | 6320 | 0.040 |
Why?
|
Electrodes | 1 | 2001 | 618 | 0.040 |
Why?
|
Anti-Arrhythmia Agents | 1 | 2003 | 775 | 0.040 |
Why?
|
Recurrence | 9 | 2003 | 8510 | 0.040 |
Why?
|
Anti-Inflammatory Agents | 1 | 2008 | 1816 | 0.040 |
Why?
|
Arm | 1 | 2021 | 590 | 0.040 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2003 | 1142 | 0.040 |
Why?
|
Diabetes Mellitus | 2 | 2007 | 5887 | 0.040 |
Why?
|
Health Resources | 1 | 2003 | 950 | 0.030 |
Why?
|
Comorbidity | 3 | 2013 | 10601 | 0.030 |
Why?
|
Cost-Benefit Analysis | 7 | 2011 | 5532 | 0.030 |
Why?
|
Entropy | 1 | 1997 | 212 | 0.030 |
Why?
|
Myocardial Contraction | 1 | 2002 | 1527 | 0.030 |
Why?
|
Models, Statistical | 3 | 2017 | 5103 | 0.030 |
Why?
|
Total Quality Management | 1 | 1997 | 264 | 0.030 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2006 | 2279 | 0.030 |
Why?
|
Laboratories, Hospital | 1 | 1997 | 192 | 0.030 |
Why?
|
Cerebrovascular Disorders | 2 | 2019 | 1487 | 0.030 |
Why?
|
Reproducibility of Results | 5 | 2014 | 20231 | 0.030 |
Why?
|
Sensitivity and Specificity | 5 | 2002 | 14728 | 0.030 |
Why?
|
Peptidyl-Dipeptidase A | 1 | 1997 | 330 | 0.030 |
Why?
|
Cardiology Service, Hospital | 1 | 1997 | 241 | 0.030 |
Why?
|
Clinical Competence | 1 | 2011 | 4841 | 0.030 |
Why?
|
Suture Techniques | 1 | 2000 | 776 | 0.030 |
Why?
|
Anticoagulants | 2 | 2022 | 4840 | 0.030 |
Why?
|
Confidence Intervals | 2 | 2012 | 2932 | 0.030 |
Why?
|
Automation | 1 | 1997 | 588 | 0.030 |
Why?
|
Laser Therapy | 1 | 2002 | 1107 | 0.030 |
Why?
|
Embolic Protection Devices | 1 | 2014 | 43 | 0.030 |
Why?
|
Stroke Volume | 2 | 2009 | 5620 | 0.030 |
Why?
|
Acute Disease | 5 | 2008 | 7246 | 0.030 |
Why?
|
Echocardiography | 3 | 2005 | 5043 | 0.030 |
Why?
|
Benchmarking | 2 | 2011 | 1058 | 0.030 |
Why?
|
Internet | 2 | 2008 | 3123 | 0.030 |
Why?
|
Systole | 1 | 1996 | 938 | 0.030 |
Why?
|
Renal Dialysis | 1 | 2003 | 1802 | 0.030 |
Why?
|
Femoral Artery | 2 | 2013 | 829 | 0.030 |
Why?
|
Disease-Free Survival | 5 | 2002 | 6856 | 0.030 |
Why?
|
Diastole | 1 | 1996 | 784 | 0.030 |
Why?
|
Diagnostic Errors | 1 | 2001 | 1282 | 0.030 |
Why?
|
Kaplan-Meier Estimate | 3 | 2010 | 6537 | 0.030 |
Why?
|
Program Development | 2 | 2011 | 1296 | 0.030 |
Why?
|
Cold Temperature | 1 | 2017 | 786 | 0.030 |
Why?
|
Age Distribution | 2 | 2009 | 2881 | 0.030 |
Why?
|
Time and Motion Studies | 2 | 2007 | 143 | 0.030 |
Why?
|
Ultrasonography, Interventional | 2 | 1998 | 1519 | 0.030 |
Why?
|
Clinical Trials as Topic | 6 | 2005 | 8051 | 0.020 |
Why?
|
Combined Modality Therapy | 4 | 2007 | 8559 | 0.020 |
Why?
|
Blood Pressure | 1 | 2008 | 8538 | 0.020 |
Why?
|
Survivors | 1 | 2002 | 2381 | 0.020 |
Why?
|
Disease Progression | 2 | 2021 | 13655 | 0.020 |
Why?
|
Emergency Medical Services | 1 | 2003 | 1948 | 0.020 |
Why?
|
Longitudinal Studies | 3 | 2014 | 14766 | 0.020 |
Why?
|
Infusions, Intra-Arterial | 2 | 2002 | 221 | 0.020 |
Why?
|
Heart Septal Defects, Atrial | 1 | 1994 | 452 | 0.020 |
Why?
|
Forecasting | 2 | 1998 | 2950 | 0.020 |
Why?
|
Cineangiography | 2 | 2002 | 108 | 0.020 |
Why?
|
Peptides | 1 | 2003 | 4368 | 0.020 |
Why?
|
Complement Fixation Tests | 1 | 1990 | 68 | 0.020 |
Why?
|
Acute Kidney Injury | 1 | 2003 | 1943 | 0.020 |
Why?
|
Aspirin | 2 | 2001 | 3139 | 0.020 |
Why?
|
Time | 2 | 2002 | 546 | 0.020 |
Why?
|
Dyspnea | 1 | 2018 | 1352 | 0.020 |
Why?
|
Risk | 3 | 2013 | 9642 | 0.020 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 1997 | 1066 | 0.020 |
Why?
|
Warfarin | 1 | 1998 | 1493 | 0.020 |
Why?
|
Reference Values | 1 | 1997 | 4941 | 0.020 |
Why?
|
Heart | 1 | 2003 | 4451 | 0.020 |
Why?
|
Ventricular Function | 2 | 2005 | 406 | 0.020 |
Why?
|
Accidental Falls | 1 | 2017 | 1081 | 0.020 |
Why?
|
Canada | 2 | 2006 | 2143 | 0.020 |
Why?
|
Signal Transduction | 2 | 2009 | 23638 | 0.020 |
Why?
|
Heart Function Tests | 1 | 2009 | 318 | 0.020 |
Why?
|
Recovery of Function | 1 | 2018 | 2994 | 0.020 |
Why?
|
Injections, Subcutaneous | 1 | 2009 | 681 | 0.020 |
Why?
|
Prevalence | 4 | 2003 | 15880 | 0.020 |
Why?
|
Propensity Score | 1 | 2014 | 1971 | 0.020 |
Why?
|
Atrial Natriuretic Factor | 1 | 2008 | 350 | 0.020 |
Why?
|
Receptor, erbB-2 | 2 | 2009 | 2586 | 0.020 |
Why?
|
Drug Utilization | 1 | 2013 | 1192 | 0.020 |
Why?
|
Advisory Committees | 1 | 2011 | 797 | 0.020 |
Why?
|
Length of Stay | 3 | 2013 | 6521 | 0.020 |
Why?
|
Caspases | 1 | 2009 | 884 | 0.020 |
Why?
|
Syndrome | 2 | 2003 | 3278 | 0.020 |
Why?
|
Blotting, Northern | 1 | 2008 | 1553 | 0.020 |
Why?
|
Severity of Illness Index | 3 | 2010 | 15965 | 0.020 |
Why?
|
Ventricular Function, Left | 2 | 2009 | 3941 | 0.020 |
Why?
|
Cause of Death | 1 | 2016 | 3727 | 0.020 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2009 | 679 | 0.020 |
Why?
|
ROC Curve | 2 | 2004 | 3624 | 0.020 |
Why?
|
Rats, Wistar | 1 | 2009 | 1891 | 0.020 |
Why?
|
Platelet Count | 1 | 2008 | 786 | 0.020 |
Why?
|
Israel | 1 | 2007 | 726 | 0.020 |
Why?
|
Ubiquitination | 1 | 2009 | 1010 | 0.010 |
Why?
|
Insurance, Health, Reimbursement | 1 | 2008 | 389 | 0.010 |
Why?
|
Aortic Valve Stenosis | 1 | 1997 | 2032 | 0.010 |
Why?
|
Eligibility Determination | 1 | 2008 | 420 | 0.010 |
Why?
|
Retreatment | 1 | 2006 | 601 | 0.010 |
Why?
|
Wounds and Injuries | 1 | 2017 | 2518 | 0.010 |
Why?
|
Controlled Clinical Trials as Topic | 1 | 2005 | 187 | 0.010 |
Why?
|
In Situ Nick-End Labeling | 1 | 2005 | 616 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 2 | 2002 | 36840 | 0.010 |
Why?
|
Sex Distribution | 1 | 2009 | 2286 | 0.010 |
Why?
|
Animals, Newborn | 1 | 2009 | 2696 | 0.010 |
Why?
|
Tachycardia, Sinus | 1 | 2003 | 43 | 0.010 |
Why?
|
Probability | 1 | 2009 | 2483 | 0.010 |
Why?
|
Emergency Service, Hospital | 1 | 2003 | 7956 | 0.010 |
Why?
|
Heart Arrest | 1 | 2013 | 1516 | 0.010 |
Why?
|
Obesity | 1 | 2005 | 13065 | 0.010 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2009 | 1322 | 0.010 |
Why?
|
Hypertrophy, Right Ventricular | 1 | 2003 | 109 | 0.010 |
Why?
|
Belgium | 1 | 2002 | 119 | 0.010 |
Why?
|
Quebec | 1 | 2002 | 139 | 0.010 |
Why?
|
Health Care Costs | 3 | 2003 | 3265 | 0.010 |
Why?
|
Xiphoid Bone | 1 | 2002 | 10 | 0.010 |
Why?
|
Medicare | 2 | 2013 | 6881 | 0.010 |
Why?
|
Linear Models | 2 | 2004 | 5880 | 0.010 |
Why?
|
Academic Medical Centers | 1 | 2013 | 2785 | 0.010 |
Why?
|
Australia | 1 | 2006 | 1264 | 0.010 |
Why?
|
Costs and Cost Analysis | 2 | 2000 | 1670 | 0.010 |
Why?
|
Glycoproteins | 1 | 2009 | 2206 | 0.010 |
Why?
|
Microscopy, Confocal | 1 | 2008 | 1977 | 0.010 |
Why?
|
Health Care Surveys | 1 | 2009 | 2437 | 0.010 |
Why?
|
Protein Processing, Post-Translational | 1 | 2009 | 1969 | 0.010 |
Why?
|
Prosthesis Failure | 1 | 2007 | 1208 | 0.010 |
Why?
|
Immunoglobulin Fab Fragments | 1 | 2003 | 447 | 0.010 |
Why?
|
Filtration | 1 | 2002 | 228 | 0.010 |
Why?
|
Regression Analysis | 2 | 2001 | 6353 | 0.010 |
Why?
|
Pilot Projects | 3 | 2002 | 8730 | 0.010 |
Why?
|
Computer Simulation | 1 | 2014 | 6278 | 0.010 |
Why?
|
Cardiac Pacing, Artificial | 1 | 2005 | 881 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2009 | 2465 | 0.010 |
Why?
|
Necrosis | 1 | 2005 | 1621 | 0.010 |
Why?
|
Up-Regulation | 1 | 2009 | 4138 | 0.010 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2009 | 2067 | 0.010 |
Why?
|
Blotting, Western | 1 | 2008 | 5042 | 0.010 |
Why?
|
South Africa | 1 | 2006 | 1870 | 0.010 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2009 | 2884 | 0.010 |
Why?
|
Prosthesis Design | 1 | 2007 | 2126 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2009 | 6527 | 0.010 |
Why?
|
Thrombolytic Therapy | 1 | 2008 | 2058 | 0.010 |
Why?
|
Guideline Adherence | 1 | 2010 | 2239 | 0.010 |
Why?
|
Collagen | 1 | 2008 | 2646 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2017 | 4877 | 0.010 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2009 | 2882 | 0.010 |
Why?
|
Insulin | 2 | 2007 | 6606 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2008 | 6242 | 0.010 |
Why?
|
Vascular Patency | 1 | 2002 | 916 | 0.010 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2008 | 1751 | 0.010 |
Why?
|
Pacemaker, Artificial | 1 | 2005 | 828 | 0.010 |
Why?
|
Europe | 1 | 2006 | 3439 | 0.010 |
Why?
|
Depression | 1 | 2018 | 8235 | 0.010 |
Why?
|
Phosphorylation | 1 | 2009 | 8332 | 0.010 |
Why?
|
Rats | 2 | 2009 | 23839 | 0.010 |
Why?
|
Endpoint Determination | 1 | 2001 | 591 | 0.010 |
Why?
|
Heterozygote | 1 | 2005 | 2792 | 0.010 |
Why?
|
Statistics as Topic | 1 | 2004 | 2362 | 0.010 |
Why?
|
Quality-Adjusted Life Years | 1 | 2004 | 1734 | 0.010 |
Why?
|
Evidence-Based Medicine | 1 | 2010 | 3708 | 0.010 |
Why?
|
Fluoroscopy | 1 | 2002 | 952 | 0.010 |
Why?
|
Diabetic Angiopathies | 1 | 2003 | 806 | 0.010 |
Why?
|
Case-Control Studies | 2 | 2008 | 22293 | 0.010 |
Why?
|
Ventricular Dysfunction, Right | 1 | 2003 | 645 | 0.010 |
Why?
|
Arteries | 1 | 2002 | 1126 | 0.010 |
Why?
|
Creatine | 1 | 1999 | 427 | 0.010 |
Why?
|
Device Removal | 1 | 2002 | 641 | 0.010 |
Why?
|
Patient Admission | 1 | 2004 | 1370 | 0.010 |
Why?
|
Demography | 1 | 2002 | 1643 | 0.010 |
Why?
|
Diagnosis, Differential | 2 | 2003 | 13026 | 0.010 |
Why?
|
Research Design | 1 | 2012 | 6217 | 0.010 |
Why?
|
Dogs | 1 | 2001 | 3847 | 0.010 |
Why?
|
Mice | 3 | 2009 | 82045 | 0.010 |
Why?
|
Drainage | 1 | 2002 | 1179 | 0.010 |
Why?
|
Secondary Prevention | 1 | 2002 | 1479 | 0.010 |
Why?
|
Mental Health | 2 | 2000 | 3271 | 0.010 |
Why?
|
Animals | 5 | 2009 | 169418 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2009 | 7599 | 0.010 |
Why?
|
Radiotherapy Dosage | 1 | 2002 | 2925 | 0.010 |
Why?
|
Safety | 1 | 2000 | 1159 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2008 | 9558 | 0.010 |
Why?
|
Health Status Indicators | 1 | 2000 | 971 | 0.010 |
Why?
|
Single-Blind Method | 1 | 1998 | 1585 | 0.010 |
Why?
|
Causality | 1 | 2001 | 1255 | 0.010 |
Why?
|
Renin | 1 | 1997 | 642 | 0.010 |
Why?
|
Medicaid | 1 | 2008 | 2843 | 0.010 |
Why?
|
Hypoglycemic Agents | 1 | 2007 | 3111 | 0.010 |
Why?
|
Radiographic Image Enhancement | 1 | 1999 | 878 | 0.010 |
Why?
|
Hemodynamics | 1 | 2005 | 4202 | 0.010 |
Why?
|
Emergencies | 1 | 2001 | 1222 | 0.010 |
Why?
|
Norepinephrine | 1 | 1997 | 900 | 0.010 |
Why?
|
Family Practice | 1 | 1997 | 510 | 0.010 |
Why?
|
Syncope | 1 | 1997 | 430 | 0.010 |
Why?
|
Lidocaine | 1 | 1997 | 545 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2009 | 19041 | 0.010 |
Why?
|
Calcium Channel Blockers | 1 | 1997 | 692 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 1999 | 2863 | 0.010 |
Why?
|
Chest Pain | 1 | 2000 | 1099 | 0.010 |
Why?
|
Constriction, Pathologic | 1 | 1997 | 1103 | 0.010 |
Why?
|
Educational Status | 1 | 2000 | 2519 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2008 | 12813 | 0.010 |
Why?
|
Fees and Charges | 1 | 1993 | 192 | 0.010 |
Why?
|
Neovascularization, Pathologic | 1 | 2002 | 2643 | 0.010 |
Why?
|
Biphenyl Compounds | 1 | 1997 | 1026 | 0.010 |
Why?
|
Models, Theoretical | 1 | 2003 | 3590 | 0.010 |
Why?
|
Catheterization | 1 | 1997 | 1431 | 0.010 |
Why?
|
Adrenergic beta-Antagonists | 1 | 1997 | 1244 | 0.010 |
Why?
|
Clinical Protocols | 1 | 1997 | 1444 | 0.010 |
Why?
|
Pain Measurement | 1 | 2001 | 3577 | 0.010 |
Why?
|
Regional Blood Flow | 1 | 1994 | 1502 | 0.010 |
Why?
|
Tetrazoles | 1 | 1997 | 922 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2009 | 22365 | 0.010 |
Why?
|
Activities of Daily Living | 1 | 2000 | 2433 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2000 | 2705 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2009 | 18388 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2005 | 14480 | 0.010 |
Why?
|
Aorta | 1 | 1997 | 2046 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2003 | 12450 | 0.000 |
Why?
|
Echocardiography, Transesophageal | 1 | 1994 | 1095 | 0.000 |
Why?
|
Antihypertensive Agents | 1 | 1997 | 2028 | 0.000 |
Why?
|
Life Expectancy | 1 | 1994 | 1249 | 0.000 |
Why?
|
Antibodies, Monoclonal | 1 | 2003 | 9263 | 0.000 |
Why?
|
Health Services Research | 1 | 1993 | 1815 | 0.000 |
Why?
|
Child | 1 | 1997 | 80863 | 0.000 |
Why?
|